{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:55:06Z","timestamp":1789419306128,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.beem.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T02:32:16Z","timestamp":1409106736000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments"],"prefix":"10.1016","volume":"29","author":[{"given":"Gregory M.","family":"Pastores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.beem.2014.08.005_bib1","first-page":"59","article-title":"Lysosomal storage disorders: old diseases, present and future challenges","volume":"11","author":"Klein","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib2","first-page":"101","article-title":"The clinical presentation of lysosomal storage disorders","volume":"13","author":"Wraith","year":"2004","journal-title":"Acta Neurol Taiwan"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2004.05293.x","article-title":"Lysosomal storage disorders","volume":"128","author":"Vellodi","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beem.2014.08.005_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajmg.1320490104","article-title":"High frequencies of human genetic diseases: founder effect with genetic drift or selection?","volume":"49","author":"Zlotogora","year":"1994","journal-title":"Am J Med Genet"},{"issue":"5\u20136","key":"10.1016\/j.beem.2014.08.005_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00439-002-0877-1","article-title":"The Finnish disease Heritage III: the individual diseases","volume":"112","author":"Norio","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.beem.2014.08.005_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0065-3101(24)00037-9","article-title":"Hydrops fetalis: lysosomal storage disorders in extremis","volume":"46","author":"Stone","year":"1999","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.beem.2014.08.005_bib7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/B978-0-444-59565-2.00042-3","article-title":"Mucopolysaccharidoses and mucolipidoses","volume":"113","author":"Wraith","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2014.08.005_bib8","first-page":"406","article-title":"Skeletal abnormalities in lysosomal storage diseases","volume":"10","author":"Stevenson","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1\u20132","key":"10.1016\/j.beem.2014.08.005_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.beem.2014.08.005_bib10","doi-asserted-by":"crossref","first-page":"NP9","DOI":"10.1177\/0883073813491627","article-title":"Hyperactivity, unexplained speech delay, and coarse facies \u2013 is it sanfilippo syndrome?","volume":"29","author":"Saini","year":"2013","journal-title":"J\u00a0Child Neurol"},{"issue":"5","key":"10.1016\/j.beem.2014.08.005_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bpg.2010.09.001","article-title":"Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly","volume":"24","author":"vom Dahl","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10545-010-9070-1","article-title":"High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease","volume":"33","author":"Taddei","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.12804","article-title":"Gaucher disease: haematological presentations and complications","volume":"165","author":"Thomas","year":"2014","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.beem.2014.08.005_bib14","first-page":"1560","article-title":"Development of a suspicion index to aid diagnosis of Niemann-Pick disease type","volume":"78","author":"Wijburg","year":"2012","journal-title":"Child Neurol"},{"issue":"6","key":"10.1016\/j.beem.2014.08.005_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.prrv.2005.06.007","article-title":"Systemic diseases and the lung","volume":"6","author":"Dinwiddie","year":"2005","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.beem.2014.08.005_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","article-title":"Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy","volume":"9","author":"Katzin","year":"2008","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.beem.2014.08.005_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00059-012-3659-0","article-title":"Genetics and metabolic cardiomyopathies","volume":"37","author":"Wicks","year":"2012","journal-title":"Herz"},{"issue":"5","key":"10.1016\/j.beem.2014.08.005_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of fabry disease in stroke patients-a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2014","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.beem.2014.08.005_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mus.23790","article-title":"Consider Danon disease in dilated cardiomyopathy with noncompaction","volume":"48","author":"St\u00f6llberger","year":"2013","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib22","first-page":"94","article-title":"Cystinosis as a lysosomal storage disease with multiple mutant alleles: phenotypic-genotypic correlations","volume":"2","author":"Al-Haggar","year":"2013","journal-title":"World J Nephrol"},{"issue":"5","key":"10.1016\/j.beem.2014.08.005_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.semnephrol.2004.06.024","article-title":"Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease","volume":"24","author":"Sessa","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.beem.2014.08.005_bib24","article-title":"Macular cherry-red spot helps diagnose rare storage disorder in an infant with repeated respiratory tract infections: case report","author":"Padhi","year":"2013","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"10.1016\/j.beem.2014.08.005_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/emmm.201302781","article-title":"Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology","volume":"5","author":"Sands","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib26","first-page":"174","article-title":"Sialidosis type I (cherry red spot-myoclonus syndrome)","volume":"102","author":"Ganguly","year":"2004","journal-title":"J\u00a0Indian Med Assoc"},{"issue":"10","key":"10.1016\/j.beem.2014.08.005_bib27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1586\/ern.11.135","article-title":"Childhood leukodystrophies: a clinical perspective","volume":"11","author":"Kohlsch\u00fctter","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"10.1016\/j.beem.2014.08.005_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-0030-1248246","article-title":"Massive hemobilia and papillomatosis of the gallbladder in metachromatic leukodystrophy: a life-threatening condition","volume":"40","author":"Garavelli","year":"2009","journal-title":"Neuropediatrics"},{"issue":"12","key":"10.1016\/j.beem.2014.08.005_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/jcp.2005.027045","article-title":"Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre","volume":"58","author":"Anderson","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"issue":"457","key":"10.1016\/j.beem.2014.08.005_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.2007.00641.x","article-title":"Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease","volume":"97","author":"Aerts","year":"2008","journal-title":"Acta Paediatr Suppl"},{"issue":"7","key":"10.1016\/j.beem.2014.08.005_bib31","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A\u00a0sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J\u00a0Lipid Res"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.beem.2014.08.005_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9592.2012.03897.x","article-title":"Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management","volume":"22","author":"Kirkpatrick","year":"2012","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"10.1016\/j.beem.2014.08.005_bib34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jclinane.2005.01.012","article-title":"Anesthesia for an adult with mucopolysaccharidosis I","volume":"17","author":"Ard","year":"2005","journal-title":"J\u00a0Clin Anesth"},{"issue":"9","key":"10.1016\/j.beem.2014.08.005_bib35","first-page":"641","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"Q\u00a0J Med"},{"issue":"1","key":"10.1016\/j.beem.2014.08.005_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2014.08.005_bib37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bmt.1704834","article-title":"Survey on haematopoietic stem cell transplantation for children in Europe","volume":"35","author":"Miano","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beem.2014.08.005_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease: principles, practice, and prospects","volume":"4","author":"Grabowski","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","article-title":"Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages","volume":"37","author":"Rombach","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.beem.2014.08.005_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J\u00a0Pediatrics"},{"issue":"8","key":"10.1016\/j.beem.2014.08.005_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A\u00a0phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.beem.2014.08.005_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J\u00a0Pediatrics"},{"issue":"17","key":"10.1016\/j.beem.2014.08.005_bib43","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/01.wnl.0000407271.54424.a2","article-title":"Recombinant human acid {alpha}-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"77","author":"Kishnani","year":"2011","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.beem.2014.08.005_bib44","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A\u00a0randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2014.08.005_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2012.04.027","article-title":"The impact of antibodies in late-onset Pompe disease: a case series and literature review","volume":"106","author":"Patel","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"10","key":"10.1016\/j.beem.2014.08.005_bib46","doi-asserted-by":"crossref","first-page":"e47805","DOI":"10.1371\/journal.pone.0047805","article-title":"Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome","volume":"7","author":"Rombach","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.beem.2014.08.005_bib47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"issue":"20","key":"10.1016\/j.beem.2014.08.005_bib48","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-06-293902","article-title":"Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.beem.2014.08.005_bib49","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1111\/j.1742-4658.2007.06043.x","article-title":"Pharmacological chaperone therapy for lysosomal storage disorders \u2013 leveraging aspects of the folding pathway to maximize activity of misfolded mutant proteins","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.beem.2014.08.005_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2014.01.005","article-title":"Pharmacological chaperoning: a primer on mechanism and pharmacology","volume":"83","author":"Leidenheimer","year":"2014","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.beem.2014.08.005_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2012.1187","article-title":"New strategies for the treatment of lysosomal storage diseases (review)","volume":"31","author":"Parenti","year":"2013","journal-title":"Int J Mol Med"},{"issue":"24","key":"10.1016\/j.beem.2014.08.005_bib52","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2174\/138161211797247578","article-title":"Gene therapy for lysosomal storage diseases: progress, challenges and future prospects","volume":"17","author":"Seregin","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"6148","key":"10.1016\/j.beem.2014.08.005_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beem.2014.08.005_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/pr.2011.13","article-title":"Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats","volume":"71","author":"Auclair","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.beem.2014.08.005_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2014.05.029","article-title":"Mesenchymal stem cells as cellular vectors for pediatric neurological disorders","volume":"1573","author":"Phinney","year":"2014","journal-title":"Brain Res"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:49:12Z","timestamp":1761497352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X14000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1521690X14000967"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2014.08.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}